Schroder Investment Management Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-104,789
| Closed | -$742K | – | 1314 |
|
|
2022
Q1 | $742K | Sell |
104,789
-1,436,317
| -93% | -$10.2M | ﹤0.01% | 1172 |
|
|
2021
Q4 | $13.8M | Buy |
1,541,106
+1,525,824
| +9,984% | +$13.6M | 0.02% | 550 |
|
|
2021
Q3 | $536K | Hold |
15,282
| – | – | ﹤0.01% | 1197 |
|
|
2021
Q2 | $328K | Sell |
15,282
-12,043
| -44% | -$258K | ﹤0.01% | 1274 |
|
|
2021
Q1 | $1.69M | Buy |
+27,325
| New | +$1.69M | ﹤0.01% | 1047 |
|